HLA B27 Detection: Flow Cytometry & PCR
- March 15,2022
- 1 Min Read

HLA-B27 - CLASS 1 MHC protein is the hallmark of the genetic component of spondyloarthritides, and about 90% of patient with ankylosing spondylitis (AS) carry this antigen - it is present in 80-95% of patients with AS, in contrast to only 8% of the general population.
Currently, there are 2 major methodologies available for the testing of HLA-B27:
-
Flow Cytometric Immunophenotypic (FCIPT)
-
Polymerase Chain Reaction (PCR)
To understand the actual real-world differences between the two methodologies in detecting HLA-B27, Suburban Diagnostics performed an 8 month study.
Our findings were:
-
0% samples tested by PCR gave a result of inconclusive/indeterminate
-
6.65% samples tested by flow cytometry gave a result of inconclusive/indeterminate
To understand the true HLA-B27 status of these indeterminate samples, we tested them with PCR and found that:
-
75% POSITIVE for HLA-B27 on PCR
-
25% NEGATIVE for HLA-B27 on PCR
Conclusion:
Only a small percentage of samples tested using FCIPT were inconclusive/indeterminate. However, most of these indeterminate samples turned out to be positive. Reflex testing with PCR for any flow cytometry samples that give an indeterminate result will give us the best of both worlds.
#unburdenhealthcare with us.
Most Viewed
Premarital Health Screening
- September 30,2020
- 20 Min Read
Typhoid - Signs and Symptoms
- March 02,2021
- 3 Min Read
Dengue
- February 28,2021
- 4 Min Read
Home Quarantine Tips
- April 01,2021
- 5 Min Read
Vitamin D and Diabetes
- March 28,2021
- 3 Min Read
Types of tests for HIV & Monitoring (Suburban Medical Journal)
- December 22,2021
- 30 Min Read
Cervical Cancer Screening
- April 01,2021
- 2 Min Read
COVID-19 Symptoms
- April 01,2021
- 3 Min Read
GeneXpert MTB/RIF: Recommended Test for Tuberculosis Diagnosis
- March 22,2022
- 2 Min Read
Utility of X-ray as initial screening tool in suspected or confirmed cases of Mucormycosis
- June 10,2021
- 2 Min Read